scholarly article | Q13442814 |
P356 | DOI | 10.1210/JC.2012-1561 |
P698 | PubMed publication ID | 22996145 |
P50 | author | Scott M Blackman | Q56867504 |
William V Tamborlane | Q65054855 | ||
T1D Exchange Clinic Network | Q65054860 | ||
Roy W. Beck | Q88156417 | ||
Kellee M Miller | Q88663907 | ||
Richard M Bergenstal | Q90594281 | ||
P2093 | author name string | Stephanie N DuBose | |
Callyn A Hall | |||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 7 | |
P304 | page(s) | 4383-4389 | |
P577 | publication date | 2012-09-20 | |
P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
P1476 | title | The T1D Exchange clinic registry | |
P478 | volume | 97 |
Q50209268 | A 5-Step Approach Protocol Using CareLink Therapy Software in Type 1 Diabetes Patients |
Q35680365 | A Minority of Patients with Type 1 Diabetes Routinely Downloads and Retrospectively Reviews Device Data. |
Q26741647 | A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes |
Q28066687 | A Review of Safety and Design Requirements of the Artificial Pancreas |
Q93002552 | A Web-Delivered Multicomponent Intervention for Adolescents with Poorly Controlled Type 1 Diabetes: A Pilot Randomized Controlled Trial |
Q36668662 | A case study in open source innovation: developing the Tidepool Platform for interoperability in type 1 diabetes management |
Q37192444 | A new-generation continuous glucose monitoring system: improved accuracy and reliability compared with a previous-generation system |
Q90664004 | A systematic review of non-genetic predictors and genetic factors of glycated haemoglobin in type 1 diabetes one year after diagnosis |
Q46136482 | Adults with type 1 diabetes: Partner relationships and outcomes |
Q50300651 | Albuminuria is associated with greater copeptin concentrations in men with type 1 diabetes: A brief report from the T1D exchange Biobank |
Q55397942 | Artificial Pancreas in Young Children. |
Q39346785 | Autoimmune Diseases in Children and Adults With Type 1 Diabetes From the T1D Exchange Clinic Registry |
Q33569031 | Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes |
Q64323443 | Beta cell function in type 1 diabetes determined from clinical and fasting biochemical variables |
Q86507149 | Bolus calculator and wirelessly communicated blood glucose measurement effectively reduce hypoglycaemia in type 1 diabetic children - randomized controlled trial |
Q47179021 | Camp-based multi-component intervention for families of young children with type 1 diabetes: A pilot and feasibility study. |
Q41656385 | Cardiovascular health in adults with type 1 diabetes |
Q33671308 | Care utilization in a pediatric diabetes clinic: cancellations, parental attendance, and mental health appointments |
Q37429171 | Challenges and future directions of the T1D Exchange Clinic Network and registry |
Q46342421 | Characteristics of youth with type 1 diabetes (T1D) with and without a parent with T1D in the T1D exchange clinic registry |
Q46075434 | Comparison of autoantibody-positive and autoantibody-negative pediatric participants enrolled in the T1D Exchange clinic registry. |
Q58569853 | Comparison of proinsulin and C-peptide secretion in healthy versus long-standing type 1 diabetes mellitus cohorts: A pilot study |
Q93216031 | Continuous Glucose Monitoring Integration in Clinical Practice: A Stepped Guide to Data Review and Interpretation |
Q92807720 | Continuous Glucose Monitoring Sensors for Diabetes Management: A Review of Technologies and Applications |
Q42320665 | Continuous Glucose Monitoring in Patients With Type 1 Diabetes Using Insulin Injections |
Q37275651 | Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics. |
Q45850120 | Contrasting the clinical care and outcomes of 2,622 children with type 1 diabetes less than 6 years of age in the United States T1D Exchange and German/Austrian DPV registries |
Q38953873 | Correlates of overweight and obesity in 5529 adolescents with type 1 diabetes: The T1D Exchange Clinic Registry |
Q98195623 | Cost-effectiveness of health technologies in adults with type 1 diabetes: a systematic review and narrative synthesis |
Q57412827 | Counter-regulatory hormone responses to hypoglycaemia in people with type 1 diabetes after 4 weeks of treatment with liraglutide adjunct to insulin: a randomized, placebo-controlled, double-blind, crossover trial |
Q36705282 | Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial |
Q37025568 | Day-and-Night Hybrid Closed-Loop Insulin Delivery in Adolescents With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial |
Q64917526 | Delay discounting associated with challenges to treatment adherence and glycemic control in young adults with type 1 diabetes. |
Q40215272 | Demographic and clinical characteristics of patients with type 1 diabetes mellitus: A multicenter registry study in Guangdong, China |
Q28083966 | Developmental changes in the roles of patients and families in type 1 diabetes management |
Q89219312 | Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital |
Q37054720 | Diabetes Technology: Uptake, Outcomes, Barriers, and the Intersection With Distress. |
Q86067459 | Diabetes: Insulin pumps in children with T1DM--we told you so |
Q47562173 | Diabetic Retinopathy and Dementia in Type 1 Diabetes |
Q37278206 | Differences in the management of type 1 diabetes among adults under excellent control compared with those under poor control in the T1D Exchange Clinic Registry |
Q89388938 | Differential association of body mass index on glycemic control in type 1 diabetes |
Q51286634 | Dissecting heterogeneity in paediatric Type 1 diabetes: association of TCF7L2 rs7903146 TT and low-risk human leukocyte antigen (HLA) genotypes. |
Q56340587 | Dyslipidaemia and statin use in individuals aged 10 to <40 years in the T1D Exchange clinic registry |
Q57177950 | Eating patterns and food intake of persons with type 1 diabetes within the T1D exchange |
Q55398504 | Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol. |
Q30378946 | Effect of auditory guided imagery on glucose levels and on glycemic control in children with type 1 diabetes mellitus. |
Q63865918 | Effect of early glycemic control on HbA1c tracking and development of vascular complications after 5 years of childhood onset type 1 diabetes: Systematic review and meta‐analysis |
Q51291232 | Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes. |
Q38306991 | Efficacy of theory-based interventions for young people with type 1 diabetes: a systematic review and meta-analysis |
Q64137088 | Emerging Approaches in Surveillance of Type 1 Diabetes |
Q93000275 | Enhancement of the Soluble Form of OX40 and OX40L Costimulatory Molecules but Reduction of the Membrane Form in Type 1 Diabetes (T1D) |
Q38824221 | Evaluation of Pump Discontinuation and Associated Factors in the T1D Exchange Clinic Registry |
Q36942273 | Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants |
Q58823053 | Exploring Variation in Glycemic Control Across and Within Eight High-Income Countries: A Cross-sectional Analysis of 64,666 Children and Adolescents With Type 1 Diabetes |
Q37106486 | Factors associated with microalbuminuria in 7,549 children and adolescents with type 1 diabetes in the T1D Exchange clinic registry |
Q90319043 | Future technology-enabled care for diabetes and hyperglycemia in the hospital setting |
Q55012488 | GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies. |
Q36726160 | Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes |
Q40522726 | Glycaemic control and its associated factors in Chinese adults with type 1 diabetes mellitus |
Q41686216 | Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison. |
Q39998144 | Glycemic control and complications in patients with type 1 diabetes - a registry-based longitudinal study of adolescents and young adults |
Q46611488 | Health Care Transition Preparation and Experiences in a U.S. National Sample of Young Adults With Type 1 Diabetes. |
Q90531569 | Health-risk Behaviors and Type 1 Diabetes Outcomes in the Transition from Late Adolescence to Early Emerging Adulthood |
Q38587713 | Health-system-based interventions to improve care in pediatric and adolescent type 1 diabetes |
Q30275746 | Heart rate informed artificial pancreas system enhances glycemic control during exercise in adolescents with T1D. |
Q30279053 | Hemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D exchange clinic registry |
Q42718199 | Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Suboptimally Controlled Adolescents With Type 1 Diabetes: A 3-Week, Free-Living, Randomized Crossover Trial |
Q39071115 | Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial |
Q90331201 | Hospital admissions for hyperglycemic emergencies in young adults at an inner-city hospital |
Q93110108 | Identification of Psychological Factors Associated with Adherence to Self-Care Behaviors amongst Patients with Type 1 Diabetes |
Q36940936 | Impact of Disease Duration on the Effects of Pramlintide in Type 1 Diabetes: A Post Hoc Analysis of Three Clinical Trials. |
Q36475961 | Improved Accuracy of Continuous Glucose Monitoring Systems in Pediatric Patients with Diabetes Mellitus: Results from Two Studies |
Q30410405 | In silico design of optimal ratio for co-administration of pramlintide and insulin in type 1 diabetes |
Q38648121 | Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): a systematic literature review |
Q47926144 | Inequalities in glycaemic control, hypoglycaemia and diabetic ketoacidosis according to socio-economic status and area-level deprivation in Type 1 diabetes mellitus: a systematic review. |
Q38743733 | Insulin Pump Use in Young Children with Type 1 Diabetes: Sociodemographic Factors and Parent-Reported Barriers. |
Q39154985 | Insulin pump failures in Italian children with Type 1 diabetes: retrospective 1-year cohort study |
Q38382412 | Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Techno |
Q44919962 | Insulin pump use in young children in the T1D Exchange clinic registry is associated with lower hemoglobin A1c levels than injection therapy |
Q38642435 | Insulin resistance, role of metformin and other non-insulin therapies in pediatric type 1 diabetes |
Q33897491 | Intensively managed young children with type 1 diabetes consume high-fat, low-fiber diets similar to age-matched controls |
Q36490455 | Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study |
Q35830445 | Intranasal glucagon: a promising approach for treatment of severe hypoglycemia |
Q39430911 | Lower A1c among adolescents with lower perceived A1c goal: a cross-sectional survey |
Q38647747 | Management and Family Burdens Endorsed by Parents of Youth <7 Years Old With Type 1 Diabetes |
Q88595487 | Management of Type 1 Diabetes With a Very Low-Carbohydrate Diet |
Q35910466 | Management of Type 1 Diabetes in Older Adults. |
Q38176514 | Management of patients with type 1 diabetes in the hospital |
Q33802296 | Managing diabetes in the digital age. |
Q36436985 | Metabolomics in childhood diabetes |
Q88732252 | Mini-Dose Glucagon as a Novel Approach to Prevent Exercise-Induced Hypoglycemia in Type 1 Diabetes |
Q34557730 | Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines |
Q47739546 | Nighttime is the worst time: Parental fear of hypoglycemia in young children with type 1 diabetes. |
Q51782163 | No Summer Vacation From Diabetes: Glycemic Control in Pediatric Participants in the T1D Exchange Registry Based on Time of Year. |
Q38777285 | Outcomes That Matter to Teens With Type 1 Diabetes |
Q53166958 | Outcomes of dialysis and the transplantation options for patients with diabetic end-stage renal disease in Korea. |
Q26782591 | Outpatient Management of Pediatric Type 1 Diabetes |
Q34283269 | Outpatient glycemic control with a bionic pancreas in type 1 diabetes |
Q89482423 | Overweight and obese children with optimal control in the T1D Exchange Registry: How are they different from lean children with optimal control? |
Q35929081 | PHYSICIANS' SELF-PERCEPTIONS OF CARE FOR EMERGING ADULTS WITH TYPE 1 DIABETES. |
Q37351231 | Pediatric diabetes consortium T1D New Onset (NeOn) study: clinical outcomes during the first year following diagnosis |
Q90731433 | Persistent elevations in circulating INS DNA among subjects with longstanding type 1 diabetes |
Q40224453 | Physical Activity in Adults With Type 1 Diabetes. |
Q38782052 | Possibilities and challenges of a large international benchmarking in pediatric diabetology-The SWEET experience |
Q38450262 | Pramlintide improved measures of glycemic control and body weight in patients with type 1 diabetes mellitus undergoing continuous subcutaneous insulin infusion therapy |
Q46726172 | Predictive hyperglycemia and hypoglycemia minimization: In-home double-blind randomized controlled evaluation in children and young adolescents |
Q90270005 | Preference for Subcutaneously Administered Low-Dose Glucagon Versus Orally Administered Glucose for Treatment of Mild Hypoglycemia: A Prospective Survey Study |
Q36382118 | Prevalence of Celiac Disease in 52,721 Youth With Type 1 Diabetes: International Comparison Across Three Continents. |
Q40833138 | Prevalence of cardiovascular risk factors in youth with type 1 diabetes and elevated body mass index |
Q44530027 | Prevalence of depression in Type 1 diabetes and the problem of over-diagnosis. |
Q26825236 | Progress of artificial pancreas devices towards clinical use: the first outpatient studies |
Q90366148 | Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes |
Q28082045 | Protocol for systematic review of evidence on the determinants and influence of early glycaemic control in childhood-onset type 1 diabetes |
Q60502200 | RETRACTED: Management and Family Burdens Endorsed by Parents of Youth <7 Years Old With Type 1 Diabetes |
Q30360577 | Racial-ethnic disparities in management and outcomes among children with type 1 diabetes. |
Q38657961 | Rationale and protocol for the After Diabetes Diagnosis REsearch Support System (ADDRESS): an incident and high risk type 1 diabetes UK cohort study. |
Q35360823 | Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry |
Q27687563 | Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile |
Q37193478 | Reduced hypoglycemia and increased time in target using closed-loop insulin delivery during nights with or without antecedent afternoon exercise in type 1 diabetes |
Q39388420 | Regulation Catches Up to Reality |
Q49495529 | Reported gastroparesis in adults with type 1 diabetes (T1D) from the T1D Exchange clinic registry |
Q28078620 | Safety and effectiveness of long-acting versus intermediate-acting insulin for patients with type 1 diabetes: protocol for a systematic review and individual patient data network meta-analysis |
Q35608590 | Salient characteristics of youth with type 1 diabetes initiating continuous glucose monitoring |
Q38901951 | Schooling diabetes: Use of continuous glucose monitoring and remote monitors in the home and school settings |
Q33908158 | Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D Exchange clinic registry |
Q39159983 | Severe hypoglycemia rates are not associated with HbA1c: a cross-sectional analysis of 3 contemporary pediatric diabetes registry databases. |
Q47173166 | Sex- and age-dependent effects of celiac disease on growth and weight gain in children with type 1 diabetes: Analysis of the type 1 diabetes Exchange Clinic Registry |
Q47440731 | Sleep in children with type 1 diabetes and their parents in the T1D Exchange |
Q91970275 | Sodium-glucose co-transporter inhibitors as adjunctive treatment to insulin in type 1 diabetes: A review of randomized controlled trials |
Q35137042 | Sotagliflozin improves glycemic control in nonobese diabetes-prone mice with type 1 diabetes |
Q47825623 | Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, th |
Q33889841 | Stepwise Approach to Problematic Hypoglycemia in Korea: Educational, Technological, and Transplant Interventions |
Q91678179 | Stressful Life Events in Young Adults With Type 1 Diabetes in the U.S. T1D Exchange Clinic Registry |
Q39013270 | Substance Use Disorders among Patients with Type 2 Diabetes: a Dangerous but Understudied Combination |
Q38372998 | Supporting patients with type 1 diabetes using continuous subcutaneous insulin infusion therapy: Difficulties, disconnections, and disarray. |
Q40474936 | Survey on the use of insulin pumps in Italy: comparison between pediatric and adult age groups (IMITA study). |
Q41196139 | Technology Use in Transition-Age Patients With Type 1 Diabetes: Reality and Promises |
Q27022145 | Technology to optimize pediatric diabetes management and outcomes |
Q37251132 | Teplizumab preserves C-peptide in recent-onset type 1 diabetes: two-year results from the randomized, placebo-controlled Protégé trial |
Q91895369 | Test of the modified dual pathway model of eating disorders in individuals with type 1 diabetes |
Q35682671 | Text messaging intervention for teens and young adults with diabetes |
Q89582065 | The Contemporary Prevalence of Diabetic Neuropathy in Type 1 Diabetes: Findings From the T1D Exchange |
Q46086150 | The effect of peer support in adults with insulin pump-treated type 1 diabetes: a pilot study of a flexible and participatory intervention. |
Q86124839 | The effect of renal hyperfiltration on urinary inflammatory cytokines/chemokines in patients with uncomplicated type 1 diabetes mellitus |
Q40735953 | The heterogeneity of islet autoantibodies and the progression of islet failure in type 1 diabetic patients |
Q93002593 | The influence of demographic, social-educational determinants and diabetes management on agreement between glucometer and logbook and its impact on glycemic control in patients with type 1 diabetes: a follow-up study |
Q40276929 | The relationship between neuropsychological assessment, numeracy, and functional status in older adults with type 1 diabetes |
Q40846148 | The role of socio-economic and clinical factors on HbA1c in children and adolescents with type 1 diabetes: an Italian multicentre survey. |
Q51257610 | The use of continuous glucose monitoring systems in a pediatric population with type 1 diabetes mellitus in real-life settings: the AWeSoMe Study Group experience. |
Q92210479 | Therapeutic Use of Intranasal Glucagon: Resolution of Hypoglycemia |
Q46608934 | Therapeutic inertia: underdiagnosed and undertreated hypertension in children participating in the T1D Exchange Clinic Registry |
Q90478418 | Time in range and HbA1C after 6 months with a multidisciplinary program for children and adolescents with diabetes mellitus, real world data from Mexico City |
Q50141722 | Timing of Meal Insulin and Its Relation to Adherence to Therapy in Type 1 Diabetes |
Q55113756 | Treatable Diabetic Retinopathy Is Extremely Rare Among Pediatric T1D Exchange Clinic Registry Participants. |
Q26853250 | Treating type 1 diabetes: from strategies for insulin delivery to dual hormonal control |
Q92982823 | Type 1 Diabetes: Disease Stratification |
Q55282195 | Type 1 diabetes care: Improvement by standardization in a diabetes rehabilitation clinic. An observational report. |
Q35920792 | Type 1 diabetes in young adulthood |
Q57148123 | Use of a Mobile App to Facilitate Blood Glucose Monitoring in Adolescents With Type 1 Diabetes: Single-Subject Nonrandomized Clinical Trial |
Q30301357 | Use of an artificial pancreas among adolescents for a missed snack bolus and an underestimated meal bolus |
Q47760524 | Using an Expert Panel to Develop Social Support Program Sequencing for Young Adults With Type 1 Diabetes |
Q36715036 | Validation of a contemporary adherence measure for children with Type 1 diabetes: the Diabetes Management Questionnaire |
Q89987125 | Value of Capillary Glucose Profiles in Assessing Risk of Nocturnal Hypoglycemia in Type 1 Diabetes Based on Continuous Glucose Monitoring |
Q46182155 | What End Users and Stakeholders Want From Automated Insulin Delivery Systems |
Q53382567 | When you come to a fork in the road, take it! |
Q39040884 | Young people with type 1 diabetes mellitus: Attitudes, perceptions, and experiences of diabetes management and continuous subcutaneous insulin infusion therapy |
Q35428773 | Youth and parent measures of self-efficacy for continuous glucose monitoring: survey psychometric properties |
Q36340511 | Youth-Perceived Burden of Type 1 Diabetes: Problem Areas in Diabetes Survey-Pediatric Version (PAID-Peds) |